Skip to main content
Paul Okunieff, MD, Radiation Oncology, Gainesville, FL, UF Health Shands Hospital

PaulGOkunieffMD

Radiation Oncology Gainesville, FL

Gastrointestinal Cancer, Thoracic Cancer, Urologic Cancer

Chairman Radiation Oncology University of Florida

Dr. Okunieff is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Okunieff's full profile

Already have an account?

Education & Training

  • Massachusetts General Hospital/Harvard Medical School
    Massachusetts General Hospital/Harvard Medical SchoolResidency, Radiology-Diagnostic, 1984 - 1987
  • Massachusetts General Hospital
    Massachusetts General HospitalResidency, Internal Medicine, 1983 - 1984
  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterInternship, Internal Medicine, 1982 - 1983
  • Harvard Medical School
    Harvard Medical SchoolClass of 1982

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2010 - 2026
  • NY State Medical License
    NY State Medical License 1997 - 2025
  • MA State Medical License
    MA State Medical License 1987 - 2025
  • American Board of Radiology Therapeutic Radiology

Awards, Honors, & Recognition

  • Top MD Consumers Checkbook

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Classification for Long-Term Survival in Oligometastatic Patients Treated with Ablative Radiotherapy: A Multi-Institutional Pooled Analysis  
    Julian C Hong, A William Blackstock, Joseph K Salama, Paul Okunieff, Michael T Milano, James J Urbanic, Ralph R Weichselbaum, Johnny Kao, Max W Sung, Steven J Chmura, PLoS One

Press Mentions

  • Seeds of Hope: UF Health Now Using Precision Radiation Procedure for Eye Cancer
    Seeds of Hope: UF Health Now Using Precision Radiation Procedure for Eye CancerSeptember 10th, 2021
  • DiaCarta, Inc., Awarded $2 Million NCI Contract to Pursue Regulatory Approval of Innovative Cancer Radiation Response Blood Test
    DiaCarta, Inc., Awarded $2 Million NCI Contract to Pursue Regulatory Approval of Innovative Cancer Radiation Response Blood TestOctober 15th, 2018
  • DiaCarta Receives NCI Contract for a Circulating Free DNA (cfDNA) Test to Monitor Radiation Response in Cancer Patients
    DiaCarta Receives NCI Contract for a Circulating Free DNA (cfDNA) Test to Monitor Radiation Response in Cancer PatientsOctober 26th, 2016
  • Join now to see all

Hospital Affiliations